24 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
(or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date … respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date
8-K
EX-10.1
0093nbrf9jwntz
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-1.1
wcp pzxo9l0nrgp3pel0
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
e22f7a3
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.1
jpug ev31aaxjdjbd
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.2
zjd3b 9jfg5
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
90yotkn
20 Aug 20
Entry into a Material Definitive Agreement
9:30am